Detection of serum human epididymis secretory protein 4 in patients with ovarian cancer using a label-free biosensor based on localized surface plasmon resonance

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 2921-2928

  Yuan, Jialing ^a   Duan, Ruiqi ^a   Yang, Huan ^b   Luo, Xiangang ^b   Xi, Mingrong ^a  

^a SICHUAN UNIVERSITY   (China)

^b INSTITUTE OF OPTICS AND ELECTRONICS   (China)

Author keywords

Localized surface plasmon resonance system; Nanobiosensor; Ovarian cancer biomarker; Serum HE4 protein

Indexed keywords

BIOLOGICAL MARKER; HUMAN EPIDIDYMIS PROTEIN 4; SILVER NANOPARTICLE;

ANTIGEN ANTIBODY REACTION; ARTICLE; BIOSENSOR; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIMIT OF DETECTION; OVARY CANCER; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; REPRODUCIBILITY; SURFACE PLASMON RESONANCE;

ANTIBODIES, IMMOBILIZED; BIOSENSING TECHNIQUES; FEMALE; HUMANS; LINEAR MODELS; METAL NANOPARTICLES; OVARIAN NEOPLASMS; PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SILVER; SURFACE PLASMON RESONANCE; TUMOR MARKERS, BIOLOGICAL;

EID: 84870321945     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S32641     Document Type: Article

References (28)

1. Anker JN, Hall WP, Lyandres O, etal. Biosensing with plasmonic nanosensors. Nat Mater. 2008;7:442-453.
2. Nam JM, Thaxton CS, Mirkin CA. Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science. 2003;301:1884-1886.
3. Haes AJ, Duyne RP. Preliminary studies and potential applications of localized surface plasmon resonance spectroscopy in medical diagnostics. Expert Rev Mol Diagn. 2004;4:527-537.
4. Haes AJ, Chang L, Klein WL, etal. Detection of a biomarker for Alzheimer's disease from synthetic and clinical samples using a nanoscale optical biosensor. J Am Chem Soc. 2005;127:2264-2271.
5. Sepúlveda B, Angelomé PC, Lechuga LM, etal. LSPR-based biosensors. Nano Today. 2009;4:244-251.
6. Monk DJ, Walt DR. Optical fiber-based biosensors. Anal Bioanal Chem. 2004;379:931-945.
7. Haes AJ, Zou SL, Schatz GC, etal. Nanoscale optical biosensor: short range distance dependence of the localized surface plasmon resonance of noble metal nanoparticles. J Phys Chem B. 2004;108:6961-6968.
8. Yonzon CR, Jeoung E, Zou S, etal. A comparative analysis of localized and propagating surface plasmon resonance sensors: the binding of concanavalin a to a monosaccharide functionalized self-assembled monolayer. J Am Chem Soc. 2004;126:2669-2676.
9. Nath N, Chilkoti A. Label-free biosensing by surface plasmon resonance of nanoparticles on glass: optimization of nanoparticle size. Anal Chem. 2004;76:5370-5378.
10. Nath N, Chilkoti A. A colorimetric gold nanoparticle sensor to interrogate biomolecular interactions in real time on a surface. Anal Chem. 2002;74:504-509.
11. Fujiwara K, Watarai H, Itoh H, etal. Measurement of antibody binding to protein immobilized on gold nanoparticles by localized surface plasmon spectroscopy. Anal Bioanal Chem. 2006;386:639-644.
12. Endo T, Yamamura S, Kerman K, etal. Label-free cell-based assay using localized surface plasmon resonance biosensor. Anal Chim Acta. 2008;614:182-189.
13. Haes AJ, Hall WP, Chang L, etal. A localized surface plasmon resonance biosensor: first steps toward an assay for Alzheimer's disease. Nano Lett. 2004;4:1029-1034.
14. Zhu SL, Li F, Du CL, etal. A localized surface plasmon resonance nanosensor based on rhombic Ag nanoparticle array. Sens Actuators B Chem. 2008;134:193-198.
15. Lai T, Hou QN, Yang H, etal. Clinical application of a novel silver nanoparticles biosensor based on localized surface plasmon resonance for detecting the microalbuminuria. Acta Biochim Biophys Sin (Shanghai). 2010;42:787-792.
16. Neesham D. Ovarian cancer screening. Aust Fam Physician. 2007;36: 126-128.
17. Hellström I, Raycraft J, Ledbetter MH, etal. The HE4(WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res. 2003;63:3695-3700.
18. Montagnana M, Danese E, Giudici S, etal. HE4in ovarian cancer: from discovery to clinical application. Adv Clin Chem. 2011;55:1-20.
19. Hellstrom I, Heagerty PJ, Swisher EM, etal. Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms. Cancer Lett. 2010;296:43-48.
20. Huhtinen K, Suvitie P, Hiisa J, etal. Serum HE4 concentration differentiates malignant ovarian tumors from ovarian endometriotic cysts. Br J Cancer. 2009;100:1315-1319.
21. Bast RC, Badgwell D, Lu Z, etal. New tumor markers: CA125 and beyond. Int J Gynecol Cancer. 2005;15:274-281.
22. Vaisocherova H, Faca VM, Taylor AD, etal. Comparative study of SPR and ELISA methods based on analysis of CD166/ALCM levels in cancer and control human sera. Biosens Bioelectron. 2009;24:2143-2148.
23. Ma WY, Yao J, Yang H, etal. Effects of vertex truncation of polyhedral nanostructures on localized surface plasmon resonance. Opt Express. 2009;17:14967-14976.
24. Doron-Mor I, Cohen H, Barkay Z, etal. Sensitivity of transmission surface plasmon resonance (T-SPR) spectroscopy: self-assembled multilayers on evaporated gold island films. Chemistry. 2005;11: 5555-5562.
25. Chalquest RR. Quantitation of indirect sandwich enzyme-linked immunosorbent assay parameters. J Clin Microbiol. 1988;26:147-148.
26. Chang XH, Ye X, Dong L, etal. Human epididymis protein 4 (HE4) as a serum tumor biomarker in patients with ovarian carcinoma. Int J Gynecol Cancer. 2011;21:852-858.
27. Krouwer JS, Tholen DW, Garber CC, etal. EP9-A2: Method Comparison and Bias Estimation Using Patient Samples: Approved Guideline, 2nd ed. Wayne, PA: National Committee for Clinical Laboratory Standards; 2002.
28. Dmitri I, Ihab AH, Plamen A, etal. Biosensors for detection of pathogenic bacteria. Biosens Bioelectron. 1999;14:599-624.